365 related articles for article (PubMed ID: 25686400)
41. Dehydroascorbic Acids-modified Polymer Micelles Target Cancer Cells to Enhance Anti-tumor Efficacy of Paclitaxel.
Pei X; Luo F; Zhang J; Chen W; Jiang C; Liu J
Sci Rep; 2017 Apr; 7(1):975. PubMed ID: 28428562
[TBL] [Abstract][Full Text] [Related]
42. Reduction-Degradable Polymeric Micelles Decorated with PArg for Improving Anticancer Drug Delivery Efficacy.
Cui Y; Sui J; He M; Xu Z; Sun Y; Liang J; Fan Y; Zhang X
ACS Appl Mater Interfaces; 2016 Jan; 8(3):2193-203. PubMed ID: 26720795
[TBL] [Abstract][Full Text] [Related]
43. Anti-cancer activity of anti-GLUT1 antibody-targeted polymeric micelles co-loaded with curcumin and doxorubicin.
Abouzeid AH; Patel NR; Rachman IM; Senn S; Torchilin VP
J Drug Target; 2013 Dec; 21(10):994-1000. PubMed ID: 24098980
[TBL] [Abstract][Full Text] [Related]
44. Stepwise targeted drug delivery to liver cancer cells for enhanced therapeutic efficacy by galactose-grafted, ultra-pH-sensitive micelles.
Yan G; Wang J; Hu L; Wang X; Yang G; Fu S; Cheng X; Zhang P; Tang R
Acta Biomater; 2017 Mar; 51():363-373. PubMed ID: 28087485
[TBL] [Abstract][Full Text] [Related]
45. The tumor accumulation and therapeutic efficacy of doxorubicin carried in calcium phosphate-reinforced polymer nanoparticles.
Min KH; Lee HJ; Kim K; Kwon IC; Jeong SY; Lee SC
Biomaterials; 2012 Aug; 33(23):5788-97. PubMed ID: 22591612
[TBL] [Abstract][Full Text] [Related]
46. Cleavable Multifunctional Targeting Mixed Micelles with Sequential pH-Triggered TAT Peptide Activation for Improved Antihepatocellular Carcinoma Efficacy.
Zhang J; Zheng Y; Xie X; Wang L; Su Z; Wang Y; Leong KW; Chen M
Mol Pharm; 2017 Nov; 14(11):3644-3659. PubMed ID: 28994600
[TBL] [Abstract][Full Text] [Related]
47. Targeted Delivery of Doxorubicin via CD147-Mediated ROS/pH Dual-Sensitive Nanomicelles for the Efficient Therapy of Hepatocellular Carcinoma.
Qu C; Li J; Zhou Y; Yang S; Chen W; Li F; You B; Liu Y; Zhang X
AAPS J; 2018 Feb; 20(2):34. PubMed ID: 29476273
[TBL] [Abstract][Full Text] [Related]
48. pH triggered doxorubicin delivery of PEGylated glycolipid conjugate micelles for tumor targeting therapy.
Hu FQ; Zhang YY; You J; Yuan H; Du YZ
Mol Pharm; 2012 Sep; 9(9):2469-78. PubMed ID: 22827551
[TBL] [Abstract][Full Text] [Related]
49. Redox-responsive star-shaped magnetic micelles with active-targeted and magnetic-guided functions for cancer therapy.
Tang Z; Zhang L; Wang Y; Li D; Zhong Z; Zhou S
Acta Biomater; 2016 Sep; 42():232-246. PubMed ID: 27373437
[TBL] [Abstract][Full Text] [Related]
50. Core-crosslinked polymeric micelles with controlled release of covalently entrapped doxorubicin.
Talelli M; Iman M; Varkouhi AK; Rijcken CJ; Schiffelers RM; Etrych T; Ulbrich K; van Nostrum CF; Lammers T; Storm G; Hennink WE
Biomaterials; 2010 Oct; 31(30):7797-804. PubMed ID: 20673684
[TBL] [Abstract][Full Text] [Related]
51. Octreotide-mediated tumor cell uptake and intracellular pH-responsive drug delivery of the self-assembly supramolecular nanocarrier.
Niu J; Huang A; Xiao Y; Su Z; Li H; Ping Q; Bao X; Li S; Chen Y; Sun M
J Drug Target; 2013 May; 21(5):415-26. PubMed ID: 23597028
[TBL] [Abstract][Full Text] [Related]
52. Enhanced doxorubicin delivery to hepatocellular carcinoma cells via CD147 antibody-conjugated immunoliposomes.
Wang J; Wu Z; Pan G; Ni J; Xie F; Jiang B; Wei L; Gao J; Zhou W
Nanomedicine; 2018 Aug; 14(6):1949-1961. PubMed ID: 29045824
[TBL] [Abstract][Full Text] [Related]
53. Sequential release of autophagy inhibitor and chemotherapeutic drug with polymeric delivery system for oral squamous cell carcinoma therapy.
Saiyin W; Wang D; Li L; Zhu L; Liu B; Sheng L; Li Y; Zhu B; Mao L; Li G; Zhu X
Mol Pharm; 2014 May; 11(5):1662-75. PubMed ID: 24666011
[TBL] [Abstract][Full Text] [Related]
54. The synergistic effect of hierarchical assemblies of siRNA and chemotherapeutic drugs co-delivered into hepatic cancer cells.
Cao N; Cheng D; Zou S; Ai H; Gao J; Shuai X
Biomaterials; 2011 Mar; 32(8):2222-32. PubMed ID: 21186059
[TBL] [Abstract][Full Text] [Related]
55. Anti-tumor efficacy of polymer-platinum(II) complex micelles fabricated from folate conjugated PEG-graft-α,β-poly [(N-amino acidyl)-aspartamide] and cis-dichlorodiammine platinum(II) in tumor-bearing mice.
Xue Y; Tang X; Huang J; Zhang X; Yu J; Zhang Y; Gui S
Colloids Surf B Biointerfaces; 2011 Jul; 85(2):280-8. PubMed ID: 21435846
[TBL] [Abstract][Full Text] [Related]
56. Hepatocellular carcinoma dually-targeted nanoparticles for reduction triggered intracellular delivery of doxorubicin.
Mezghrani O; Tang Y; Ke X; Chen Y; Hu D; Tu J; Zhao L; Bourkaib N
Int J Pharm; 2015 Jan; 478(2):553-68. PubMed ID: 25455765
[TBL] [Abstract][Full Text] [Related]
57. Well-Defined Redox-Sensitive Polyethene Glycol-Paclitaxel Prodrug Conjugate for Tumor-Specific Delivery of Paclitaxel Using Octreotide for Tumor Targeting.
Yin T; Wu Q; Wang L; Yin L; Zhou J; Huo M
Mol Pharm; 2015 Aug; 12(8):3020-31. PubMed ID: 26086430
[TBL] [Abstract][Full Text] [Related]
58. Carboxymethyl chitosan based redox-responsive micelle for near-infrared fluorescence image-guided photo-chemotherapy of liver cancer.
Yan T; Hui W; Zhu S; He J; Liu Z; Cheng J
Carbohydr Polym; 2021 Feb; 253():117284. PubMed ID: 33278950
[TBL] [Abstract][Full Text] [Related]
59. Brefeldin A delivery nanomicelles in hepatocellular carcinoma therapy: Characterization, cytotoxic evaluation in vitro, and antitumor efficiency in vivo.
Zhang JM; Jiang YY; Huang QF; Lu XX; Wang GH; Shao CL; Liu M
Pharmacol Res; 2021 Oct; 172():105800. PubMed ID: 34363949
[TBL] [Abstract][Full Text] [Related]
60. Biodegradation and Toxicity of Protease/Redox/pH Stimuli-Responsive PEGlated PMAA Nanohydrogels for Targeting Drug delivery.
Jin S; Wan J; Meng L; Huang X; Guo J; Liu L; Wang C
ACS Appl Mater Interfaces; 2015 Sep; 7(35):19843-52. PubMed ID: 26288386
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
